- Corporate Officers - G
- Gagnon Robert E.
Insider Trading History of Gagnon Robert E.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gagnon Robert E. since 2015.
This trader's CIK number is 1504983.
At the time of last reporting, Gagnon Robert E. was the Chief Financial Officer of Opus Genetics, Inc.. (stock ticker symbol IRD).
Also see all insider trading activities at Opus Genetics, Inc..
Note that in the past
Gagnon Robert E. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Opus Genetics, Inc. (IRD) by Gagnon Robert E.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | IRD | 0 | $0 | 7,842 | $40,660 | 0 | $0 |
Yearly summary of insider trading at Harvard Bioscience Inc (HBIO) by Gagnon Robert E.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | HBIO | 0 | $0 | 456,047 | $2,440,069 | 287,500 | $1,253,106 |
| 2017 | HBIO | 1,000 | $2,330 | 0 | $0 | 0 | $0 |
| 2016 | HBIO | 25,000 | $58,450 | 0 | $0 | 0 | $0 |
| 2015 | HBIO | 4,500 | $13,635 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Verastem, Inc. (VSTM) by Gagnon Robert E.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | VSTM | 0 | $0 | 1,132 | $8,970 | 0 | $0 |
| 2024 | VSTM | 0 | $0 | 20,068 | $235,692 | 0 | $0 |
| 2023 | VSTM | 0 | $0 | 6,553 | $13,528 | 0 | $0 |
| 2022 | VSTM | 0 | $0 | 52,836 | $66,149 | 0 | $0 |
| 2021 | VSTM | 0 | $0 | 5,497 | $12,478 | 0 | $0 |
Insider trading activities at 3 companies by Gagnon Robert E.:
1. Opus Genetics, Inc. (IRD)
2. Harvard Bioscience Inc (HBIO)
3. Verastem, Inc. (VSTM)
Table 1. Insider trading of Opus Genetics, Inc. (IRD) by Gagnon Robert E.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-04-23 | IRD | Sale | 7,842 | 5.18 | 40,660 |
Table 2. Insider trading of Harvard Bioscience Inc (HBIO) by Gagnon Robert E.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-08-29 | HBIO | Sale | 8,889 | 5.77 | 51,289 |
| 2018-08-07 | HBIO | Option Ex | 87,500 | 4.66 | 408,012 |
| 2018-08-07 | HBIO | Sale | 100,015 | 6.08 | 608,091 |
| 2018-07-27 | HBIO | Sale | 62,514 | 5.54 | 346,327 |
| 2018-07-27 | HBIO | Option Ex | 50,000 | 4.21 | 210,750 |
| 2018-07-24 | HBIO | Sale | 5,570 | 5.25 | 29,242 |
| 2018-07-23 | HBIO | Sale | 1,465 | 5.25 | 7,691 |
| 2018-07-19 | HBIO | Sale | 1,100 | 5.25 | 5,775 |
| 2018-07-13 | HBIO | Sale | 1,062 | 5.25 | 5,575 |
| 2018-07-12 | HBIO | Sale | 9,145 | 5.25 | 48,011 |
| 2018-07-12 | HBIO | Option Ex | 5,828 | 4.12 | 24,011 |
| 2018-07-10 | HBIO | Option Ex | 13,700 | 4.31 | 59,046 |
| 2018-07-09 | HBIO | Option Ex | 14,200 | 4.31 | 61,201 |
| 2018-07-11 | HBIO | Sale | 141,300 | 5.23 | 738,999 |
| 2018-07-10 | HBIO | Sale | 13,700 | 5.38 | 73,706 |
| 2018-07-09 | HBIO | Sale | 14,200 | 5.41 | 76,822 |
| 2018-07-11 | HBIO | Option Ex | 116,272 | 4.21 | 490,086 |
| 2018-03-07 | HBIO | Sale | 97,087 | 4.62 | 448,541 |
| 2017-05-26 | HBIO | Buy | 1,000 | 2.33 | 2,330 |
| 2016-11-02 | HBIO | Buy | 5,000 | 2.33 | 11,650 |
| 2016-11-03 | HBIO | Buy | 20,000 | 2.34 | 46,800 |
| 2015-11-12 | HBIO | Buy | 1,500 | 2.93 | 4,395 |
| 2015-11-09 | HBIO | Buy | 3,000 | 3.08 | 9,240 |
Table 3. Insider trading of Verastem, Inc. (VSTM) by Gagnon Robert E.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-12-16 | VSTM | Sale | 283 | 9.14 | 2,586 |
| 2025-09-16 | VSTM | Sale | 281 | 9.99 | 2,807 |
| 2025-06-16 | VSTM | Sale | 284 | 5.65 | 1,604 |
| 2025-03-17 | VSTM | Sale | 284 | 6.95 | 1,973 |
| 2024-12-16 | VSTM | Sale | 285 | 4.54 | 1,293 |
| 2024-12-19 | VSTM | Sale | 130 | 4.37 | 568 |
| 2024-09-19 | VSTM | Sale | 131 | 2.79 | 365 |
| 2024-09-16 | VSTM | Sale | 287 | 2.80 | 803 |
| 2024-06-17 | VSTM | Sale | 283 | 3.49 | 987 |
| 2024-06-20 | VSTM | Sale | 131 | 3.21 | 420 |
| 2024-03-18 | VSTM | Sale | 283 | 10.71 | 3,030 |
| 2024-03-19 | VSTM | Sale | 130 | 10.38 | 1,349 |
| 2024-02-06 | VSTM | Sale | 9,204 | 13.70 | 126,094 |
| 2024-01-12 | VSTM | Sale | 9,204 | 10.95 | 100,783 |
| 2023-12-18 | VSTM | Sale | 284 | 7.64 | 2,169 |
| 2023-12-19 | VSTM | Sale | 130 | 7.73 | 1,004 |
| 2023-09-18 | VSTM | Sale | 278 | 9.91 | 2,754 |
| 2023-09-19 | VSTM | Sale | 130 | 9.84 | 1,279 |
| 2023-06-16 | VSTM | Sale | 283 | 9.92 | 2,807 |
| 2023-06-20 | VSTM | Sale | 130 | 10.30 | 1,339 |
| 2023-03-16 | VSTM | Sale | 3,654 | .40 | 1,461 |
| 2023-03-20 | VSTM | Sale | 1,664 | .43 | 715 |
| 2022-12-16 | VSTM | Sale | 12,408 | .40 | 4,963 |
| 2022-12-19 | VSTM | Sale | 1,429 | .37 | 528 |
| 2022-06-21 | VSTM | Sale | 1,351 | 1.14 | 1,540 |
| 2022-05-16 | VSTM | Sale | 16,627 | 1.03 | 17,125 |
| 2022-03-21 | VSTM | Sale | 1,409 | 1.27 | 1,789 |
| 2022-01-03 | VSTM | Sale | 19,612 | 2.05 | 40,204 |
| 2021-12-20 | VSTM | Sale | 5,497 | 2.27 | 12,478 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gagnon Robert E.
(Chief Financial Officer of Opus Genetics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.